+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Companion Diagnostic Markets - The Future of Diagnostics by Application, Technology and Funding with Customized Forecasting/Analysis, and Executive and Consultant Guides

  • ID: 5187352
  • Report
  • May 2022
  • Region: Global
  • 465 Pages
  • Howe Sound Research
Companion Diagnostics Bouncing Back from Pandemic. New Diagnostic Industry comes into View

FEATURED COMPANIES

  • 10x Genomics, Inc
  • Biodesix Inc.
  • Circulogene
  • Genomic Health
  • Janssen Diagnostics
  • Precipio
Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future.  Find out the latest outlook for this important market.

Will Personalized Companion Diagnostics become the norm for diagnostics?

Learn all about how diagnostic players are jockeying for positions with their pharmaceutical counterparts and creating new and significant business opportunities. And some players are already taking the lead. It is a dynamic market situation with enormous opportunities. Diagnostic companies are trying to back the right horse. The science is racing forward. And the cost of molecular diagnostics continues to fall.

Companion Diagnostic Markets, the future of diagnostics. By Application, Technology and Funding with customized forecasting/analysis and Executive and Consultant Guides 2021-2025 provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2022 United States Medicare Fee Payment Schedules to help understand the New Nucleic Acid Test Pricing in detail.  Forecast demand for new testing regimes or technologies. Make research investment decisions. Specific growth and market size estimates for your area of interest are normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. 

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country or specific area in the world is available to purchasers of the report.

The report includes four-year market forecasts.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 10x Genomics, Inc
  • Biodesix Inc.
  • Circulogene
  • Genomic Health
  • Janssen Diagnostics
  • Precipio

1 Market Guides 
1.1 Companion Diagnostic Market - Strategic Situation Analysis  
1.2 Guide for Executives, Marketing, Sales and Business Development Staff 
1.3 Guide for Management Consultants and Investment Advisors 

2 Introduction and Market Definition  
2.1 What are Companion Diagnostics?
2.2 The Personalized Medicine Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Methodology  
2.4.1 Authors
2.4.2 Sources
2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics

3 Market Overview
3.1 Players in dynamic Market
3.1.1 Academic Research Lab  
3.1.2 Diagnostic Test Developer
3.1.3 Instrumentation Supplier
3.1.4 Distributor and Reagent Supplier  
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Office Labs
3.1.9 Audit Body  
3.1.10 Certification Body
3.2 Personalized Medicine and Companion Diagnostics
3.2.1 Basics
3.2.2 Method
3.2.3 Disease risk assessment  
3.2.4 Applications
3.2.5 Diagnosis and intervention
3.2.5.1 Companion Diagnostics
3.2.6 Drug development and usage
3.2.7 Respiratory proteomics  
3.2.8 Cancer genomics  
3.2.9 Population screening
3.2.10 Challenges  
3.2.11 Regulatory oversight  
3.2.12 Intellectual property rights
3.2.13 Reimbursement policies
3.2.14 Patient privacy and confidentiality  
3.3 Chromosomes, Genes and Epigenetics  
3.3.1 Chromosomes
3.3.2 Genes  
3.3.3 Epigenetics
3.4 Cancer Genes
3.4.1 Germline vs Somatic  
3.4.2 Changing Clinical Role  
3.5 Structure of Industry Plays Part
3.5.1 New Pharmaceutical Funding Market
3.5.2 Economies of Scale
3.5.2.1 Hospital vs. Central Lab  
3.5.3 Physician Office Labs
3.5.4 Physicians and POCT  

4 Market Trends
4.1 Factors Driving Growth  
4.1.1 Level of Care
4.1.2 Immuno-oncology
4.1.3 Liability
4.1.4 Aging Population
4.2 Factors Limiting Growth
4.2.1 State of Knowledge
4.2.2 Genetic Blizzard
4.2.3 Protocol Resistance
4.2.4 Regulation and coverage
4.3 Instrumentation and Automation
4.3.1 Instruments Key to Market Share
4.3.2 Bioinformatics Plays Role
4.4 Diagnostic Technology Development
4.4.1 Next Generation Sequencing Fuels Revolution
4.4.2 Single Cell Genomics Changes the Picture
4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment.  
4.4.4 CGES Testing, Brave New World
4.4.5 Biochips/Giant magneto resistance based assay.  

5 Companion Diagnostics Recent Developments
5.1 Recent Developments Importance and How to Use This Section  
5.1.1 Importance of These Developments
5.1.2 How to Use This Section  
5.2 Burning Rock Secures Lung Cancer NGS Test Approval in China  
5.3 TenSixteen Bio Developing Drugs, Companion NGS Tests  
5.4 Guardant Health Plans New Comprehensive Assay
5.5 Thermo Fisher, Oncocyte Ink Comarketing Deal for Cancer IVDs
5.6 Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test  
5.7 Japanese Approves Thermo Fisher Scientific Oncomine Assay as CDx
5.8 Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug  
5.9 Natera Aims to Lead Market in Solid Tumor Adjuvant CDx
5.10 Oncocyte Details Expansions Plans  
5.11 Agilent Acquires Resolution Biosciences
5.12 Qiagen, Inovio Expand CDx Partnership
5.13 AmoyDx, AstraZeneca Strike Ovarian Cancer CDx Alliance
5.14 NeoGenomics to Grow Through CDx Agreements, Acquisitions
5.15 Personalis Neoantigen Platform Driving Improved Immunotherapy Prediction
5.16 Biocartis Collaborating with Endpoint Health on CDx Tests for Idylla Platform
5.17 FDA Approves Foundation Medicine Test as CDx for Three Targeted Therapies
5.18 Promega to Develop MSI Assay as CDx
5.19 Guardant Health to Develop CDx for Janssen  
5.20 Burning Rock Bio, CStone Pharmaceuticals to Codevelop CDx
5.21 FDA Approval for FoundationOne®CDx
5.22 FDA finalizes CDx Guidance
5.23 QIAGEN Launches CDx Therascreen BRAF Test

6 Profiles of Key Players
6.1 10x Genomics, Inc
6.2 Abbott Diagnostics  
6.3 AccuraGen Inc
6.4 Adaptive Biotechnologies
6.5 Aethlon Medical  
6.6 Agena Bioscience, Inc
6.7 Agilent
6.8 Anchor Dx
6.9 ANGLE plc
6.10 ApoCell, Inc
6.11 ArcherDx, Inc
6.12 ARUP Laboratories
6.13 Asuragen
6.14 AVIVA Biosciences
6.15 Baylor Miraca Genetics Laboratories
6.16 Beckman Coulter Diagnostics
6.17 Becton, Dickinson and Company  
6.18 BGI Genomics Co. Ltd
6.19 Bioarray Genetics
6.20 Biocartis
6.21 Biocept, Inc.  
6.22 Biodesix Inc.  
6.23 BioFluidica
6.24 BioGenex  
6.25 BioIVT
6.26 Biolidics Ltd
6.27 bioMérieux Diagnostics
6.28 Bioneer Corporation
6.29 Bio-Rad Laboratories, Inc
6.30 Bio-Reference Laboratories
6.31 Bio-Techne
6.32 Bioview  
6.33 Bolidics  
6.34 Boreal Genomics  
6.35 Bristol-Myers Squibb  
6.36 Cancer Genetics  
6.37 Caris Molecular Diagnostics
6.38 Castle Biosciences, Inc
6.39 CellMax Life  
6.40 Cepheid (now Danaher)
6.41 Charles River Laboratories
6.42 Chronix Biomedical  
6.43 Circulogene  
6.44 Clinical Genomics
6.45 Cynvenio
6.46 Cytolumina Technologies Corp
6.47 CytoTrack  
6.48 Datar Cancer Genetics Limited  
6.49 Diagnologix LLC
6.50 Diasorin S.p.A
6.51 Enzo Life Sciences, Inc
6.52 Epic Sciences
6.53 Epigenomics AG
6.54 Eurofins Scientific  
6.55 Exosome Diagnostics
6.56 Exosome Sciences
6.57 Fabric Genomics  
6.58 Fluidigm Corp
6.59 Fluxion Biosciences
6.60 Foundation Medicine  
6.61 Freenome  
6.62 GeneFirst Ltd
6.63 Genetron Health (Beijing) Co., Ltd
6.64 Genomic Health
6.65 GenomOncology
6.66 GILUPI Nanomedizin
6.67 Grail, Inc
6.68 Guardant Health  
6.69 HalioDx  
6.70 HansaBiomed
6.71 HeiScreen  
6.72 Helomics
6.73 Horizon Discovery
6.74 HTG Molecular Diagnostics
6.75 iCellate  
6.76 Illumina  
6.77 Incell Dx
6.78 Inivata
6.79 Integrated Diagnostics
6.80 Invivogen  
6.81 Invivoscribe
6.82 Janssen Diagnostics
6.83 MDNA Life SCIENCES, Inc
6.84 MDx Health
6.85 Menarini Silicon Biosystems  
6.86 Millipore Sigma
6.87 Miltenyi Biotec  
6.88 MIODx
6.89 miR Scientific
6.90 Molecular MD
6.91 MyCartis
6.92 Myriad Genetics/Myriad RBM
6.93 NantHealth, Inc
6.94 Natera
6.95 NeoGenomics  
6.96 New Oncology
6.97 Novogene Bioinformatics Technology Co., Ltd
6.98 Oncocyte 
6.99 OncoDNA
6.100 Ortho Clinical Diagnostics
6.101 Oxford Nanopore Technologies
6.102 Panagene
6.103 Perkin Elmer
6.104 Personal Genome Diagnostics
6.105 Personalis
6.106 Precipio
6.107 PrecisionMed
6.108 Promega
6.109 Qiagen Gmbh  
6.110 Rarecells SAS
6.111 RareCyte
6.112 Roche Molecular Diagnostics
6.113 Screencell
6.114 Sense Biodetection
6.115 Serametrix
6.116 Siemens Healthineers
6.117 Silicon Biosystems  
6.118 simfo GmbH  
6.119 Singlera Genomics Inc
6.120 Singulomics
6.121 SkylineDx
6.122 Stratos Genomics
6.123 Sysmex Inostics 
6.124 Tempus Labs, Inc
6.125 Thermo Fisher Scientific Inc
6.126 Thrive Earlier Detection
6.127 Todos Medical  
6.128 Trovagene
6.129 Volition  
6.130 Vortex Biosciences

7 The Global Market for Companion Diagnostics
7.1 Global Market Overview by Country
7.1.1 Table Global Market by Country  
7.1.2 Chart Global Market by Country  
7.2 Global Market by Application Overview
7.2.1 Table Global Market by Application
7.2.2 Chart Global Market by Application Base/Final Year Comparison
7.2.3 Chart Global Market by Application Base Year  
7.2.4 Chart Global Market by Application Final Year
7.2.5 Chart Global Market by Application Share by Year
7.3 Global Market Funding Source Overview
7.3.1 Table Global Market by Funding Source
7.3.2 Chart Global Market Funding Source Base/Final Year Comparison  
7.3.3 Chart Global Market Funding Source Base Year
7.3.4 Chart Global Market Funding Source Final Year 
7.3.5 Chart Global Market Funding Source Share by Year  
7.4 Global Market Technology Overview  
7.4.1 Table Global Market by Technology
7.4.2 Chart Global Market Technology Base/Final Year Comparison
7.4.3 Chart Global Market Technology Base Year
7.4.4 Chart Global Market Technology Final Year
7.4.5 Chart Global Market Technology Share by Year

8 Global Companion Diagnostic Markets By Application
8.1 Oncology  
8.1.1 Table Oncology by Country
8.1.2 Chart Oncology Growth
8.2 Neurology
8.2.1 Table Neurology by Country
8.2.2 Chart Neurology Growth
8.3 Cardiology
8.3.1 Table Cardiology by Country
8.3.2 Chart Cardiology Growth  
8.4 Other Applications
8.4.1 Table Other Applications by Country
8.4.2 Chart Other Application Growth  

9 Global Companion Diagnostic Markets Funding Source  
9.1 Global Market Pharmaceutical  
9.1.1 Table Pharmaceutical by Country
9.1.2 Chart Pharmaceutical Growth
9.2 Global Market Venture
9.2.1 Table Venture by Country
9.2.2 Chart Venture Growth
9.3 Global Market Clinical
9.3.1 Table Clinical by Country  
9.3.2 Chart Clinical Growth
9.4 Global Market Other Funding
9.4.1 Table Other Funding by Country  
9.4.2 Chart Other Funding Growth

10 Global Companion Diagnostic Markets Technology
10.1 Global Market Next Generation Sequencing
10.1.1 Table Next Generation Sequencing by Country
10.1.2 Chart Next Generation Sequencing Growth
10.2 Global Market PCR  
10.2.1 Table PCR by Country
10.2.2 Chart PCR Growth  
10.3 Global Market IHC/ISH
10.3.1 Table IHC/ISH by Country  
10.3.2 Chart IHC/ISH Growth
10.4 Global Market Other Technology
10.4.1 Table Other Technology by Country
10.4.2 Chart Other Technology Growth  

11 Appendices
11.1 United States Medicare System: January 2022 Clinical Laboratory Fees Schedule
11.2 Pharmacogenomic Biomarkers in Drug Labeling  

Table of Tables 
Table 1 Market Players by Type
Table 2 The Base Pairs
Table 3 Five Factors Driving Growth
Table 4 Four Factors Limiting Growth
Table 5 Key Diagnostic Laboratory Technology Trends
Table 6 Next Generation Sequencing Technologies Speed and Cost  
Table 7 Global Companion Diagnostic Market by Region  
Table 8 Global Market by Application  
Table 9 Global Market by Funding Source
Table 10 Global Market by Technology
Table 11 Oncology by Country  
Table 12 Neurology by Country
Table 13 Cardiology by Country
Table 14 Other Applications by Country
Table 15 Pharmaceutical by Country
Table 16 Venture by Country  
Table 17 Clinical by Country  
Table 18 Other Funding by Country
Table 19 Next Generation Sequencing by Country
Table 20 PCR by Country
Table 21 IHC/ISH by Country  
Table 22 Other Technology by Country
Table 23 2022 Clinical Laboratory Fee Schedule  
Table 24 Pharmacogenomic Biomarkers  

Table of Figures 

Figure 1 FDA Approved Companion Diagnostics
Figure 2 Global Health Care Spending
Figure 3 The Lab Testing Pie  
Figure 4 DNA Strands and Chromosomes
Figure 5 Karyogram of Human Chromosomes
Figure 6 Size of Various Genomes
Figure 7 Germline vs Somatic Mutations  
Figure 8 Comparing Genomic Diagnostic and Traditional Testing
Figure 9 Percentage of World Population Over 65
Figure 10 Base Year Country Market Share Chart
Figure 11 CDx Market by Application Base vs. Final Year  
Figure 12 CDx Market by Application Base Year  
Figure 13 CDx Market by Application Final Year
Figure 14 Application Type Share by Year
Figure 15 Funding Source Base vs. Final Year
Figure 16 Funding Source Market Base Year
Figure 17 Funding Source Market Final Year
Figure 18 Funding Source Share by Year
Figure 19 Technology Base vs. Final Year
Figure 20 Technology Market Base Year
Figure 21 Technology Market Final Year
Figure 22 Technology Share by Year 
Figure 23 Oncology Growth
Figure 24 Neurology Growth
Figure 25 Cardiology Growth
Figure 26 Other Application Growth  
Figure 27 Pharmaceutical Growth
Figure 28 Venture Growth
Figure 29 Clinical Growth
Figure 30 Other Funding Growth
Figure 31 Next Generation Sequencing Growth
Figure 32 PCR Growth
Figure 33 IHC/ISH Growth
Figure 34 Other Technology Growth

Note: Product cover images may vary from those shown

Loading
LOADING...

  • 10x Genomics, Inc
  • Abbott Diagnostics  
  • AccuraGen Inc
  • Adaptive Biotechnologies
  • Aethlon Medical  
  • Agena Bioscience, Inc
  • Agilent
  • Anchor Dx
  • ANGLE plc
  • ApoCell, Inc
  • ArcherDx, Inc
  • ARUP Laboratories
  • Asuragen
  • AVIVA Biosciences
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company  
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocartis
  • Biocept, Inc.  
  • Biodesix Inc.  
  • BioFluidica
  • BioGenex  
  • BioIVT
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Reference Laboratories
  • Bio-Techne
  • Bioview  
  • Bolidics  
  • Boreal Genomics  
  • Bristol-Myers Squibb  
  • Cancer Genetics  
  • Caris Molecular Diagnostics
  • Castle Biosciences, Inc
  • CellMax Life  
  • Cepheid (now Danaher)
  • Charles River Laboratories
  • Chronix Biomedical  
  • Circulogene  
  • Clinical Genomics
  • Cynvenio
  • Cytolumina Technologies Corp
  • CytoTrack  
  • Datar Cancer Genetics Limited  
  • Diagnologix LLC
  • Diasorin S.p.A
  • Enzo Life Sciences, Inc
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific  
  • Exosome Diagnostics
  • Exosome Sciences
  • Fabric Genomics  
  • Fluidigm Corp
  • Fluxion Biosciences
  • Foundation Medicine  
  • Freenome  
  • GeneFirst Ltd
  • Genetron Health (Beijing) Co., Ltd
  • Genomic Health
  • GenomOncology
  • GILUPI Nanomedizin
  • Grail, Inc
  • Guardant Health  
  • HalioDx  
  • HansaBiomed
  • HeiScreen  
  • Helomics
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • iCellate  
  • Illumina  
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invivogen  
  • Invivoscribe
  • Janssen Diagnostics
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Menarini Silicon Biosystems  
  • Millipore Sigma
  • Miltenyi Biotec  
  • MIODx
  • miR Scientific
  • Molecular MD
  • MyCartis
  • Myriad Genetics/Myriad RBM
  • NantHealth, Inc
  • Natera
  • NeoGenomics  
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd
  • Oncocyte 
  • OncoDNA
  • Ortho Clinical Diagnostics
  • Oxford Nanopore Technologies
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Qiagen Gmbh  
  • Rarecells SAS
  • RareCyte
  • Roche Molecular Diagnostics
  • Screencell
  • Sense Biodetection
  • Serametrix
  • Siemens Healthineers
  • Silicon Biosystems  
  • simfo GmbH  
  • Singlera Genomics Inc
  • Singulomics
  • SkylineDx
  • Stratos Genomics
  • Sysmex Inostics 
  • Tempus Labs, Inc
  • Thermo Fisher Scientific Inc
  • Thrive Earlier Detection
  • Todos Medical  
  • Trovagene
  • Volition  
  • Vortex Biosciences
Note: Product cover images may vary from those shown

Loading
LOADING...